Showing results (671-680 of 705) with videos related to

Sort By:
Pageof 71
Proceedings of the National Academy of Sciences of the United States of America|May 30, 2009
ATP8B1 is essential for maintaining normal hearingJanneke M Stapelbroek, Theo A Peters, Denis H A van Beurden, et al.
European Radiology|August 29, 2013
Dynamic contrast-enhanced and ultra-high-resolution breast MRI at 7.0 TeslaBertine L Stehouwer, Dennis W J Klomp, Maurice A A J van den Bosch, et al.
NMR in Biomedicine|November 19, 2019
Feasibility of 31 P spectroscopic imaging at 7 T in lung carcinoma patientsQuincy Q van Houtum, Firdaus F A A Mohamed Hoesein, Joost J J C Verhoeff, et al.
Biorxiv : the Preprint Server for Biology|January 23, 2026
Dordaviprone/ONC201 Activation of the ClpP Mitochondrial Protease Inhibits the Growth of KRAS-Mutant Pancreatic Cancer and Overcomes RAS Inhibitor ResistanceKristina Drizyte-Miller, Seamus E Degan, Ryan D Mouery, et al.
The Journal of Biological Chemistry|October 24, 2021
The KRAS-regulated kinome identifies WEE1 and ERK coinhibition as a potential therapeutic strategy in KRAS-mutant pancreatic cancerJ Nathaniel Diehl, Jennifer E Klomp, Kayla R Snare, et al.
Biorxiv : the Preprint Server for Biology|May 4, 2026
Characterization and therapeutic suppression of KEAP1-NRF2-driven resistance to KRAS inhibitors in pancreatic and lung cancerWen-Hsuan Chang, Alec J Vaughan, Addison G Stamey, et al.
Digestive Diseases (Basel, Switzerland)|October 15, 2024
Treatment of Colorectal Lung Metastases: Two Centers Retrospective StudyMyrtle F Krul, Jan M van Rees, Amihan M de Boer, et al.
Science Translational Medicine|October 23, 2024
Stromal reprogramming overcomes resistance to RAS-MAPK inhibition to improve pancreas cancer responses to cytotoxic and immune therapyXiuting Liu, John M Baer, Meredith L Stone, et al.
Pageof 71